PDL BioPharma, Inc.

PDL BioPharma, Inc.

PDL BioPharma, Inc.

Overview
Date Founded

1986

Headquarters

34801 Campus Drive,Fremont, CA 94555

Type of Company

Public

Employees (Worldwide)

87

Industries

Biotechnology
Hospitals & Patient Services
Medical Support Services

Company Description

PDL BioPharma, Inc. produces and markets biopharmaceutical products. It operates through the following segments: Income Generating Assets, Pharmaceutical, and Medical Devices. The Income Generating Assets segment consists of revenues derived from notes and other long-term receivables, royalty rights-at fair value, equity investments, and royalties from issued patents in the United States and elsewhere. The Pharmaceutical segment covers revenues from branded prescription medicine products being sold under the name Tekturna and Tekturna HCT in the United States, and Rasilez and Rasilez HCT for the rest of the world. The Medical Devices segment handles revenues from the LENSAR Laser System sales. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Incline Village, NV.

Website
Contact Data
Trying to get in touch with decision makers at PDL BioPharma, Inc.? Subscribe today to access their professional contact information.
Executives & Employees

Director & Chief Executive Officer

President

Chief Financial Officer & Vice President

Secretary, Vice President & General Counsel

Deputy General Counsel

Owner

Partner

General Manager

Account Executive

Board of Directors

Executive Vice President & Chief Financial Officer at Incyte Corp.

President & Chief Executive Officer at S-G Management LLC

Senior Advisor at Moelis & Co.

Vice Chancellor, Business Development, Innovation & Partnerships at University of California - San Francisco

Former Secretary, Executive Vice President & General Counsel at Boston Scientific Corporation

Chairman, President & Chief Executive Officer at Xeris Pharmaceuticals, Inc.

Director & Chief Executive Officer at PDL BioPharma, Inc.

Chief Development Officer at Protagonist Therapeutics, Inc.

Former Senior Vice President, Policy & Finance at Eli Lilly & Company

Paths to PDL BioPharma, Inc.
Potential Connections via
Relationship Science
You
PDL BioPharma, Inc.
Owners & Shareholders
Details Hidden

Kestrel Investment Management Corp. is a value manager that focuses on investments in the stocks of companies that are undergoing voluntary restructurings. The firm's investment selection process is based on the use of cash flow and financial screens. Kestrel typically holds individual portfolio investments for 18 months to 3 years. They do not diversify solely to achieve industry or sector representation. Kestrel avoids stock market timing and macroeconomic forecasting, relying instead on identifying unrecognized microeconomic trends and misperceived factors. Kestrel seeks to remain fully-invested.

Details Hidden

Nine Chapters Capital Management (NCCM) employs a range of quantitative tools to identify profit opportunities, construct portfolios in a cost-efficient manner, and manage the overall risk of the portfolio consistent with the goal of producing risk-adjusted returns. The firm uses proprietary portfolio construction, risk management and execution tools to construct a portfolio of long and short positions in equities and other liquid instruments and to control its overall risk by hedging certain systematic risks. NCCM manages alternative investment vehicles that take long and short positions primarily in equities and other liquid financial instruments by combining multiple trading strategies designed to generate return through long-term and short-term market price patterns. The funds' main objective is to achieve consistent and risk-adjusted investment returns through research-driven and quantitative methods that seek to maximize the ratio of returns to risk. While the funds tend to focus on U.S. equities and related instruments, they may in the future expand to other regions, including but not limited to Europe, Asia Pacific and Latin America, including certain emerging markets. NCCM usees proprietary portfolio construction, risk management and execution tools to construct a portfolio of long and short positions in equities and other liquid instruments and to control its overall risk by hedging certain systematic risks. The funds also trade currency forwards to hedge currency risk. The funds generally employ leverage in pursuing their investment strategies.

Details Hidden

Kestrel Investment Management Corp. is a value manager that focuses on investments in the stocks of companies that are undergoing voluntary restructurings. The firm's investment selection process is based on the use of cash flow and financial screens. Kestrel typically holds individual portfolio investments for 18 months to 3 years. They do not diversify solely to achieve industry or sector representation. Kestrel avoids stock market timing and macroeconomic forecasting, relying instead on identifying unrecognized microeconomic trends and misperceived factors. Kestrel seeks to remain fully-invested.

Recent Transactions
Details Hidden

purchases Abbott Biotherapeutics Corp. from PDL BioPharma, Inc.

Details Hidden

purchases PDL BioPharma, Inc.

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Auditor

Advised on purchases PDL BioPharma, Inc.

Legal Advisor

Advised on purchases PDL BioPharma, Inc.

Investment Advisor

Advised on purchases Abbott Biotherapeutics Corp. from PDL BioPharma, Inc.

Advisors & Consultants
Legal Advisor

Partner at Irell & Manella LLP

Legal Advisor

Partner at Weil, Gotshal & Manges LLP

Legal Advisor

Partner at King & Spalding LLP

Clients

McKesson is dedicated to delivering the vital medicines, medical supplies and information technologies that enable the health care industry to provide patients better, safer care. McKesson is made up of many businesses, all serving the health care industry. Our businesses fall into one of two primary categories: Distribution solutions. We are the largest pharmaceutical distributor in North America, distributing one-third of the medicines used every day. As one of the leading pharmaceutical companies, we supply more than 40,000 U.S. pharmacy locations, from Wal-Mart to the Department of Veterans Affairs to community pharmacies and hospitals. McKesson is also one of the leading medical supply companies and distributes medical-surgical supplies and homecare supplies. Healthcare Technology solutions. We develop and install healthcare information technology systems that eliminate the need for paper prescriptions and paper medical records. Our software and hardware are used in more than 70% of the nation's hospitals with more than 200 beds. Our hospital information system solutions include electronic health record system (EHR) and clinical decision support system such as Interqual. McKesson's Healthcare IT division also serves diverse areas within the health industry by offering solutions such as pharmacy automation and medical claims management software. McKesson publicly traded on NYSE under MCK Businesses Serving our customers—pharmacies, medical and pharmaceutical manufacturers, hospitals, and insurers—as the health care industry evolves is our primary goal. We have business lines to automate processes from medical supplies packaging to claims management, and revenue cycle management to medical imaging. McKesson's long history in pharmaceutical industry History McKesson has a long history in health care. We’ve been a trusted provider of medical supplies and goods for more than 175 years.

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded on in 1984 and is headquartered in Dublin, Ireland.

Cardinal Health, Inc. is a healthcare services company providing pharmaceutical and medical products. It operates through the Pharmaceutical and Medical segments. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products in the United States, and operates nuclear pharmacies and cyclotron facilities, provides pharmacy management services to hospitals as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, provides services to healthcare companies supporting the development, marketing, and distribution of specialty pharmaceutical products, and repackages generic pharmaceuticals and over-the-counter healthcare products. The Medical segment distributes a broad range of medical, surgical and laboratory products and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers in the United States, Canada and China; as well as manufactures, sources and develops own Cardinal Health brand medical and surgical products, which are sold in the United States, Canada, Europe and other regions internationally, and provides post-acute care management and transition services and software to hospitals, other healthcare providers and payers. The company was founded by Robert D. Walter in 1971 and is headquartered in Dublin, OH.

Key Stats and Financials As of 2017
Market Capitalization
$386M
Total Enterprise Value
$140M
Earnings Per Share
$0.71
Revenue
$320M
Enterprise Value Sales
0.44x
TEVNet Income
1.26x
Debt TEV
1.75x
Total Equity
$846M
Net Profit
$111M
Total Debt
$243M
EBITDAMargin
68.37%
Enterprise Value EBITDAOperating
0.64x
EBITDA
$219M
Three Year Compounded Annual Growth Rate Of Revenue
-18.21%
Five Year Compounded Annual Growth Rate Of Revenue
-3.19%
Non-Profit Donations & Grants
Suppliers
Coherent, Inc. Industrial Machinery & Manufacturing | Santa Clara, California

Founded in 1966, Coherent, Inc. is one of the world's leading providers of lasers and laser-based solutions for scientific, commercial and industrial customers competing in the most demanding markets.

Novartis AG Hospitals & Patient Services | Basel, BS

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Alcon, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Alcon segment researches, develops, manufactures, distributes and sells eye care devices and vision care. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.